Rosuvastatin & Fenofibrate Tablets IP – Noruva F Tablets

NORUVA F Tablets
Composition:- Rosuvastatin 10mg + Fenofibrate 160mg

NORUVA F Tablets – The dual combination of Rosuvastatin & Fenofibrate Tablets IP provides comprehensive lipid management in patients with dyslipidemia:
Rosuvastatin – A potent statin used to lower cholesterol levels. It reduces LDL cholesterol (the “bad” cholesterol), increases HDL cholesterol (the “good” cholesterol), and slows the progression of atherosclerosis.
Fenofibrate – A fibrate that primarily targets high triglyceride levels, lowers triglycerides, and modestly increases HDL cholesterol.

Key Points of Rosuvastatin & Fenofibrate Tablets – NORUVA F Tablets
• Dual Lipid Control – Effectively targets both high LDL and triglycerides, ideal for mixed dyslipidemia.
• Enhanced Heart Protection – Provides comprehensive cardiovascular risk reduction, especially for high-risk patients.
• Synergistic Action – Rosuvastatin lowers LDL, while Fenofibrate reduces triglycerides for optimal lipid management.
• Faster Results – Achieves significant lipid reduction quicker than single-drug therapies.
• Prevents Lipid-related Complications – Reduces the risk of atherosclerosis and other lipid-related cardiovascular issues.

Can be Prescribed by:
• Cardiologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.